Erschienen in:
01.05.2006 | Short Report
Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome
verfasst von:
Nicola Strnad-Trojan, Richard Linde, Janine Reichenbach, Jörg Trojan, Stefan Zeuzem, Stefan Zielen
Erschienen in:
European Journal of Pediatrics
|
Ausgabe 5/2006
Einloggen, um Zugang zu erhalten
Abstract
Chronic hepatitis C (HCV) infection in patients with primary immunodeficiency increases the risk of an accelerated progression of HCV-related liver disease. Here, we report a patient with X-linked lymphoproliferative syndrome infected with HCV and Epstein-Barr virus (EBV). After combination treatment with interferon α-2b and ribavirin, clearance of HCV-RNA was achieved, and noteworthily, EBV DNA also became undetectable.